
Chinese regenerative medicine company founded in February 2013 in the national biological industry base in the Pingshan district of Shenzhen, Guangdong, holding national high-tech enterprise status with equity investment from the Shenzhen municipal government. Works on cell and gene engineering and cell therapy development and clinical translation across five thousand square metres of buildings housing a cell resource bank, a clinical biosample bank, an intelligent cell factory and a central laboratory. Its products, technologies and services cover stem cell preparations, 3D printed stem cell products, stem cell extracts, immune cell preparations, serum free media, cell bioreactors and cell storage, and it has filed more than a hundred and thirty patents including ninety-two invention patents.
会社プロフィールを見る
評価を残す